← Back to Search

Behavioral Intervention

Electronically Connected Health Coaching in Type 2 Diabetes

Phase 3
Waitlist Available
Led By Paul Ritvo, PhD
Research Sponsored by York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months follow up from baseline
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

Patients with Type 2 Diabetes randomly allocated to the intervention arm (health coaching + smartphone-based health promotion software) will have significantly better Hemoglobin A1c levels at 6 months post-intervention than patients with Type 2 Diabetes allocated to the control arm (health coaching alone).

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months follow up from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months follow up from baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hemoglobin A1c
Secondary study objectives
Center for Epidemiological Studies Depression Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Lifestyle counseling with smartphonesExperimental Treatment1 Intervention
Lifestyle counseling assisted by smartphones
Group II: Lifestyle counselingActive Control1 Intervention
Lifestyle counseling

Find a Location

Who is running the clinical trial?

Public Health Agency of Canada (PHAC)OTHER_GOV
49 Previous Clinical Trials
99,232 Total Patients Enrolled
York UniversityLead Sponsor
63 Previous Clinical Trials
521,276 Total Patients Enrolled
Paul Ritvo, PhDPrincipal InvestigatorYork University
2 Previous Clinical Trials
96 Total Patients Enrolled
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top